Skip to Main Content

Paper Details

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer.
EClinicalMedicine
8
2023
Author NameAffiliation
Celestia S HiganoUniversity of Washington, Fred Hutchinson Cancer Research Center
Oliver SartorTulane Cancer Center, Tulane University School of Medicine
Peter S ContiKeck School of Medicine of USC
Cora N SternbergEnglander Institute for Precision Medicine, Meyer Cancer Center, New York-Presbyterian Hospital
Fred SaadUniversity of Montreal Hospital Center
  • 1 - 5

Datasets